drugset / Trial / NCT00312286
Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was to evaluate efficacy of 851B gel over a range of concentrations and dosing regimens on high-risk cervical human papillomavirus infection in women.
Timeline
- Start
- 2006-04
- Primary completion
- 2008-06
- Completion
- 2008-06
Outcome
Outcome not reported
Stopped: “Lack of efficacy”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | 851B | Small molecule | 0.15 % | Topical |
| Comparator | 851B | Small molecule | 1.5 % | Topical |
| Comparator | 851B | Small molecule | 3 % | Topical |